Bingqiang Wen1, Enhong Li1, Vladimir Ustiyan1, Guolun Wang1, Minzhe Guo2,3, Cheng-Lun Na2, Gregory T Kalin1, Veronica Galvan4, Yan Xu2,3, Timothy E Weaver2,3, Tanya V Kalin2,3, Jeffrey A Whitsett2,3,5, Vladimir V Kalinichenko1,2,3,5. 1. Center for Lung Regenerative Medicine, Perinatal Institute. 2. Division of Pulmonary Biology, and. 3. Division of Developmental Biology, Cincinnati Children's Research Foundation, Cincinnati, Ohio. 4. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; and. 5. Department of Cellular and Integrative Physiology and The Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Abstract
Rationale: The regeneration and replacement of lung cells or tissues from induced pluripotent stem cell- or embryonic stem cell-derived cells represent future therapies for life-threatening pulmonary disorders but are limited by technical challenges to produce highly differentiated cells able to maintain lung function. Functional lung tissue-containing airways, alveoli, vasculature, and stroma have never been produced via directed differentiation of embryonic stem cells (ESCs) or induced pluripotent stem cells. We sought to produce all tissue components of the lung from bronchi to alveoli by embryo complementation. Objectives: To determine whether ESCs are capable of generating lung tissue in Nkx2-1-/- mouse embryos with lung agenesis. Methods: Blastocyst complementation was used to produce chimeras from normal mouse ESCs and Nkx2-1-/- embryos, which lack pulmonary tissues. Nkx2-1-/- chimeras were examined using immunostaining, transmission electronic microscopy, fluorescence-activated cell sorter analysis, and single-cell RNA sequencing.Measurements and Main Results: Although peripheral pulmonary and thyroid tissues are entirely lacking in Nkx2-1 gene-deleted embryos, pulmonary and thyroid structures in Nkx2-1-/- chimeras were restored after ESC complementation. Respiratory epithelial cell lineages in restored lungs of Nkx2-1-/- chimeras were derived almost entirely from ESCs, whereas endothelial, immune, and stromal cells were mosaic. ESC-derived cells from multiple respiratory cell lineages were highly differentiated and indistinguishable from endogenous cells based on morphology, ultrastructure, gene expression signatures, and cell surface proteins used to identify cell types by fluorescence-activated cell sorter.Conclusions: Lung and thyroid tissues were generated in vivo from ESCs by blastocyst complementation. Nkx2-1-/- chimeras can be used as "bioreactors" for in vivo differentiation and functional studies of ESC-derived progenitor cells.
Rationale: The regeneration and replacement of lung cells or tissues from induced pluripotent stem cell- or embryonic stem cell-derived cells represent future therapies for life-threatening pulmonary disorders but are limited by technical challenges to produce highly differentiated cells able to maintain lung function. Functional lung tissue-containing airways, alveoli, vasculature, and stroma have never been produced via directed differentiation of embryonic stem cells (ESCs) or induced pluripotent stem cells. We sought to produce all tissue components of the lung from bronchi to alveoli by embryo complementation. Objectives: To determine whether ESCs are capable of generating lung tissue in Nkx2-1-/- mouse embryos with lung agenesis. Methods: Blastocyst complementation was used to produce chimeras from normal mouse ESCs and Nkx2-1-/- embryos, which lack pulmonary tissues. Nkx2-1-/- chimeras were examined using immunostaining, transmission electronic microscopy, fluorescence-activated cell sorter analysis, and single-cell RNA sequencing.Measurements and Main Results: Although peripheral pulmonary and thyroid tissues are entirely lacking in Nkx2-1 gene-deleted embryos, pulmonary and thyroid structures in Nkx2-1-/- chimeras were restored after ESC complementation. Respiratory epithelial cell lineages in restored lungs of Nkx2-1-/- chimeras were derived almost entirely from ESCs, whereas endothelial, immune, and stromal cells were mosaic. ESC-derived cells from multiple respiratory cell lineages were highly differentiated and indistinguishable from endogenous cells based on morphology, ultrastructure, gene expression signatures, and cell surface proteins used to identify cell types by fluorescence-activated cell sorter.Conclusions: Lung and thyroid tissues were generated in vivo from ESCs by blastocyst complementation. Nkx2-1-/- chimeras can be used as "bioreactors" for in vivo differentiation and functional studies of ESC-derived progenitor cells.
Entities:
Keywords:
Nkx2-1 transcription factor; blastocyst complementation; generation of lung tissue from embryonic stem cells; lung development; lung regenerative medicine for pediatric lung diseases
Authors: Il-Man Kim; Yan Zhou; Sneha Ramakrishna; Douglas E Hughes; Julian Solway; Robert H Costa; Vladimir V Kalinichenko Journal: J Biol Chem Date: 2005-09-06 Impact factor: 5.157
Authors: Katherine B McCauley; Finn Hawkins; Maria Serra; Dylan C Thomas; Anjali Jacob; Darrell N Kotton Journal: Cell Stem Cell Date: 2017-03-30 Impact factor: 24.633
Authors: Natarajan Muthusamy; Hui-Chen Chen; Girish Rajgolikar; Kenneth G Butz; Frank W Frissora; Richard M Gronostajski Journal: Int Immunol Date: 2011-05-19 Impact factor: 4.823
Authors: Hongping Xia; Xiaomeng Ren; Craig S Bolte; Vladimir Ustiyan; Yufang Zhang; Tushar A Shah; Tanya V Kalin; Jeffrey A Whitsett; Vladimir V Kalinichenko Journal: Am J Respir Cell Mol Biol Date: 2015-05 Impact factor: 6.914
Authors: Yuqi Cai; Craig Bolte; Tien Le; Chinmayee Goda; Yan Xu; Tanya V Kalin; Vladimir V Kalinichenko Journal: Sci Signal Date: 2016-04-19 Impact factor: 8.192
Authors: Tanya V Kalin; Lucille Meliton; Angelo Y Meliton; Xiangdong Zhu; Jeffrey A Whitsett; Vladimir V Kalinichenko Journal: Am J Respir Cell Mol Biol Date: 2008-04-17 Impact factor: 6.914
Authors: Guolun Wang; Bingqiang Wen; Xiaomeng Ren; Enhong Li; Yufang Zhang; Minzhe Guo; Yan Xu; Jeffrey A Whitsett; Tanya V Kalin; Vladimir V Kalinichenko Journal: Am J Respir Crit Care Med Date: 2021-08-01 Impact factor: 30.528
Authors: Alberto Posabella; Andrea B Alber; Hendrik J Undeutsch; Raoul A Droeser; Anthony N Hollenberg; Laertis Ikonomou; Darrell N Kotton Journal: Front Endocrinol (Lausanne) Date: 2021-04-20 Impact factor: 5.555
Authors: Olena A Kolesnichenko; Jeffrey A Whitsett; Tanya V Kalin; Vladimir V Kalinichenko Journal: Am J Respir Cell Mol Biol Date: 2021-11 Impact factor: 6.914
Authors: Fei Sun; Guolun Wang; Arun Pradhan; Kui Xu; Jose Gomez-Arroyo; Yufang Zhang; Gregory T Kalin; Zicheng Deng; Ronald J Vagnozzi; Hua He; Andrew W Dunn; Yuhua Wang; Allen J York; Rashmi S Hegde; Jason C Woods; Tanya V Kalin; Jeffery D Molkentin; Vladimir V Kalinichenko Journal: Circulation Date: 2021-06-11 Impact factor: 39.918